Anti-tumor immune cells in peripheral blood predominantly consist of T cells, NK cells, DC cells, macrophages, and B cells, with CD8+ T cells being the primary drivers of the anti-tumor immune response (5). The gene discussed is CD8A; the disease is neoplasm.